The effect of dehydroepiandrosterone sulfate administration to patients with multi-infarct dementia

Journal of the Neurological Sciences

Volumn 162, Issue 1, 1999, Pages 69-73

  Azuma, Tsutomu ^a   Nagai, Yoshitaka ^a   Saito, Toshio ^a   Funauchi, Masahiro ^a   Matsubara, Tsuyoshi ^a   Sakoda, Saburo ^b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cerebrospinal fluid; Dehydroepiandrosterone sulfate; Multi infarct dementia

Indexed keywords

PRASTERONE SULFATE;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; DEHYDROEPIANDROSTERONE SULFATE; DEMENTIA, MULTI-INFARCT; EMOTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOIMMUNOASSAY;

EID: 0032921563     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00295-0     Document Type: Article

References (29)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., American Psychiatric Association, Washington, DC, 1987:103-122.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., American Psychiatric Association, Washington, DC, 1994:143-147.
3. Azuma T., Matsubara T., Shima Y.et al. Neurosteroids in cerebrospinal fluid in neurologic disorders. J Neurol Sci. 120:1993;87-92.
4. Baulieu E.E. Studies of conjugated 17-ketosteroids in a case of adrenal tumor. J Clin Endocrinol Metab. 22:1962;501-510.
5. Blauer K.L., Poth M., Rogers W.M., Bernton E.W. Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology. 129:1991;3174-3179.
6. Bologa L., Sharma J., Roberts E. Dehydroepiandrosterone and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures. J Neurosci Res. 17:1987;225-234.
7. Cascio C., Parasad V.V.K., Lin Y.Y.et al. Detection of P450c17-independent pathways for dehydroepiandrosterone (DHEA) biosynthesis in brain glial tumor cells. Proc Natl Acad Sci USA. 95:1998;2862-2867.
8. Corpéchot C., Robel P., Axelson M.et al. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci USA. 78:1981;4704-4707.
9. Corpéchot C., Synguelakis M., Talha S.et al. Pregnenolone and its sulfate ester in the rat brain. Brain Res. 270:1983;119-125.
10. Flood J.F., Smith G.E., Roberts E. Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res. 447:1988;269-278.
11. Folstein M.F., Folstein S.E., McHugh P.R. 'Mini-Mental State.' A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:1975;189-198.
12. Henderson V.W. Estrogen, cognition, and a woman's risk of Alzheimer's disease. Am J Med. 103(3A):1997;1S-18S.
13. Kawata M. Roles of steroid hormones and their receptors in structural organization in the nervous system. Neurosci Res. 24:1995;1-46.
14. Lacroix C., Fiet J., Benais J.P.et al. Simultaneous radioimmunoassay of progesterone, androst-4-enedione, pregnenolone, dehydroepiandrosterone and 17-hydroxyprogesterone in specific regions of human brain. J Steroid Biochem. 28:1987;317-325.
15. Leblhuber F., Peichl M., Neubauer C.et al. Serum dehydroepiandrosterone and cortisol measurements in Huntington's chorea. J Neurol Sci. 132:1995;76-79.
16. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S.C. Effects of replacement dose of dehydroepiandrosterone in man and woman of advancing age. J Clin Endocrinol Metab. 78:1994;1360-1367.
17. Mortola J.F., Yen S.S.C. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. 71:1990;696-704.
18. Näsman B., Olsson T., Bäckström T.et al. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and multi-infarct dementia. Biol Psychat. 30:1991;684-690.
19. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 59:1984;551-555.
20. Prasad V.V.K., Vegesna S.R., Welch M., Lieberman S. Precursors of the neurosteroids. Proc Natl Acad Sci USA. 91:1994;3220-3223.
21. Reisberg B. Dementia: A systematic approach to identifying reversible causes. Geriatrics. 41:1986;30-46.
22. Rhodes M.E., Li P.K., Flood J.F., Johnson D.A. Enhancement of hippocampal acetylcholine release by the neurosteroid dehydroepiandrosterone sulfate: An in vivo microdialysis study. Brain Res. 733:1996;284-286.
23. Rice M.M., Graves A.B., McCurry S.M., Larson E.B. Estrogen replacement therapy and cognitive function in postmenopausal women without dementia. Am J Med. 103(3A):1997;26S-35S.
24. Robel P., Bourreau E., Corpéchot C.et al. Neuro-steroids: 3-β-hydroxy-Δ5-derivatives in rat and monkey brain. J Steroid Biochem. 27:1987;649-655.
25. Sapolsky R.M., Pulsinelli W.A. Glucocorticoid potentiate ischemic injury to neurons: Therapeutic implications. Science. 229:1985;1397-1400.
26. Sarter M., Schneider H.H., Stephens D.N. Treatment strategies for senile dementia: Antagonist β-carbolines. Trends Neurosci. 11:1987;13-17.
27. Sherman B., Wysham C., Pfohl B. Age-related changes in the circadian rhythm of plasma cortisol in man. J Clin Endocrinol Metab. 61:1985;439-443.
28. A receptors in ventral midbrain neurons by a neurosteroid dehydroepiandrosterone sulfate. Synapse. 16:1994;113-122.
29. Venault P., Chapouthier G., de Carvalho L.P.et al. Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks. Nature. 321:1986;864-866.